Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions
Alexander Filatenkov, Jeanette B Baker, Antonia M. S. Müller et al. · Clinical Cancer Research · 2015
PURPOSE: The goals of the study were to elucidate the immune mechanisms that contribute to desirable complete remissions of murine colon tumors treated with single radiation dose of 30 Gy. This dose is at the upper end of the ablative range used clinically to treat advanced or metastatic colorectal, liver, and non-small cell lung tumors. EXPERIMENTAL DESIGN: Changes in the tumor immune microenvironment of single tumor nodules exposed to radiation were studied using 21-day (>1 cm in diameter) CT26 and MC38 colon tumors. These are well-characterized weakly immunogenic tumors. RESULTS: We found that the high-dose radiation transformed the immunosuppressive tumor microenvironment resulting in an intense CD8(+) T-cell tumor infiltrate, and a loss of myeloid-derived suppressor cells (MDSC). The change was dependent on antigen cross-presenting CD8(+) dendritic cells, secretion of IFNγ, and CD4(+)T cells expressing CD40L. Antitumor CD8(+) T cells entered tumors shortly after radiotherapy, reversed MDSC infiltration, and mediated durable remissions in an IFNγ-dependent manner. Interestingly, extended fractionated radiation regimen did not result in robust CD8(+) T-cell infiltration. CONCLUSIONS: For immunologically sensitive tumors, these results indicate that remissions induced by a short course of high-dose radiotherapy depend on the development of antitumor immunity that is reflected by the nature and kinetics of changes induced in the tumor cell microenvironment. These results suggest that systematic examination of the tumor immune microenvironment may help in optimizing the radiation regimen used to treat tumors by adding a robust immune response.
Cited by 474 works. doi:10.1158/1078-0432.ccr-14-2824 Open-access PDF
Authors
- Alexander Filatenkov
- Jeanette B Baker
- Antonia M. S. Müller
- Justin A. Kenkel
- G‐One Ahn
- Suparna Dutt
- Nigel Zhang
- Holbrook E K Kohrt
- Kent P. Jensen
- Sussan Dejbakhsh‐Jones
- Judith A. Shizuru
- Robert S. Negrin
- Edgar G. Engleman
- Samuel Strober
References
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
- Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- Immunogenic Cell Death in Cancer Therapy
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
- Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo